237 related articles for article (PubMed ID: 20356942)
1. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England.
Duffy SW; Tabar L; Olsen AH; Vitak B; Allgood PC; Chen TH; Yen AM; Smith RA
J Med Screen; 2010; 17(1):25-30. PubMed ID: 20356942
[TBL] [Abstract][Full Text] [Related]
2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
[TBL] [Abstract][Full Text] [Related]
3. Benefit-to-harm ratio of the Danish breast cancer screening programme.
Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
[TBL] [Abstract][Full Text] [Related]
4. The benefits and harms of breast cancer screening: an independent review.
Independent UK Panel on Breast Cancer Screening
Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
[TBL] [Abstract][Full Text] [Related]
5. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
[TBL] [Abstract][Full Text] [Related]
6. Absolute numbers of lives saved and overdiagnosis in breast cancer screening.
Junod B; Spinosa JP
J Med Screen; 2010; 17(2):103; author reply 103. PubMed ID: 20660442
[No Abstract] [Full Text] [Related]
7. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
[TBL] [Abstract][Full Text] [Related]
8. A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England.
Blyuss O; Dibden A; Massat NJ; Parmar D; Cuzick J; Duffy SW; Sasieni P
Cancer Med; 2023 Jan; 12(2):1878-1887. PubMed ID: 35851849
[TBL] [Abstract][Full Text] [Related]
9. Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program.
Hofvind S; Román M; Sebuødegård S; Falk RS
J Med Screen; 2016 Dec; 23(4):203-209. PubMed ID: 26940960
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
11. Some issues in screening for breast and other cancers.
Duffy SW; McCann J; Godward S; Gabe R; Warwick J
J Med Screen; 2006; 13 Suppl 1():S28-34. PubMed ID: 17227639
[TBL] [Abstract][Full Text] [Related]
12. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits.
Berrington de González A; Reeves G
Br J Cancer; 2005 Sep; 93(5):590-6. PubMed ID: 16136033
[TBL] [Abstract][Full Text] [Related]
13. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
Harding C; Pompei F; Burmistrov D; Wilson R
Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
[TBL] [Abstract][Full Text] [Related]
14. The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.
Duffy SW; Tabar L; Vitak B; Day NE; Smith RA; Chen HH; Yen MF
Eur J Cancer; 2003 Aug; 39(12):1755-60. PubMed ID: 12888371
[TBL] [Abstract][Full Text] [Related]
15. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.
Yen AM; Duffy SW; Chen TH; Chen LS; Chiu SY; Fann JC; Wu WY; Su CW; Smith RA; Tabár L
Cancer; 2012 Dec; 118(23):5728-32. PubMed ID: 22605639
[TBL] [Abstract][Full Text] [Related]
16. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
17. Radiation risk of breast screening in England with digital mammography.
Warren LM; Dance DR; Young KC
Br J Radiol; 2016 Nov; 89(1067):20150897. PubMed ID: 27585843
[TBL] [Abstract][Full Text] [Related]
18. Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results.
Tabar L; Vitak B; Chen HH; Prevost TC; Duffy SW
Swiss Surg; 1999; 5(5):199-204. PubMed ID: 10546517
[TBL] [Abstract][Full Text] [Related]
19. European breast cancer service screening outcomes: a first balance sheet of the benefits and harms.
Paci E; Broeders M; Hofvind S; Puliti D; Duffy SW;
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1159-63. PubMed ID: 24991022
[TBL] [Abstract][Full Text] [Related]
20. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
